Strategic Planning, Delivery & AI Implementation for Life Sciences Companies
Navari Consulting partners with multinational pharma organisations to plan and deliver complex initiatives, turn data into decisions, and build AI products that hold up under regulatory and commercial scrutiny.
Years combined consulting experience
Core advisory disciplines
Multinational pharma focus
Headquartered in Dublin
Advisory built for pharma's complexity
From strategic planning through to AI-enabled delivery, we bring the discipline multinational pharmaceutical organisations need and the pragmatism their timelines demand.
Project & Programme Management
End-to-end delivery leadership for complex, cross-functional pharma initiatives — on time, on budget, and audit-ready.
Learn moreStrategic Planning & Portfolio Advisory
Structured planning frameworks that align portfolios, resourcing, and governance to long-term commercial objectives.
Learn moreData Analytics & Business Insights
Turning fragmented commercial and operational data into clear, decision-ready insight for leadership teams.
Learn moreAI Product Management & Strategy
Roadmapping and delivering AI products designed for pharma's regulatory, quality, and governance requirements.
Learn moreDigital Transformation & Change Management
Guiding organisations through technology-led change with structured adoption and stakeholder alignment.
Learn moreCommercial Operations & Insights
Sharpening market access, brand, and field-force analytics to strengthen commercial decision-making.
Learn moreBuilt around pharma's operating reality
Pharma domain fluency
We understand regulatory, quality, and compliance constraints — so recommendations are usable, not theoretical.
Delivery discipline
Rigorous project and programme management practices keep multinational initiatives on track and accountable.
Evidence-led insight
Decisions grounded in clean data and clear analysis, not assumptions or vendor-driven narratives.
AI-ready thinking
Practical AI product management that balances innovation with the governance pharma demands.